Experimental murine amyloidosis II: effect of penicillamine therapy.
D-penicillamine was used in 2 different doses to treat experimental amyloidosis in mice. No beneficial effect, as measured by duration of survival or amount of amyloid in the liver, could be demonstrated.
D000686:Amyloidosis / Q000188:drug therapy*; D000818:Animals; D005260:Female; D008107:Liver Diseases / Q000188:drug therapy; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D010396:Penicillamine / Q000627:therapeutic use*
D010396:Penicillamine